The expression levels of several MD resistant genes such as granzyme A (GZMA), IFNG, IL10, TPD52L1, IGF-I, and CXCL12 were significantly different between the tumorous spleens and the spleens of survivors, which was in line with our former microarray data described by Lian et al. [32]. The gene discussed is GZMA; the disease is neoplasm.